2025
Cardiac Magnetic Resonance Imaging in Immune Checkpoint Inhibitor–Related Myocarditis
Hammer M, Tysarowski M, Fuss C, Bader A. Cardiac Magnetic Resonance Imaging in Immune Checkpoint Inhibitor–Related Myocarditis. Echocardiography 2025, 42: e70131. PMID: 40067334, DOI: 10.1111/echo.70131.Peer-Reviewed Original ResearchConceptsImmune-related adverse eventsImmune checkpoint inhibitorsCardiac magnetic resonance imagingMagnetic resonance imagingAssociated with immune-related adverse eventsCardiac immune-related adverse eventsMechanisms of immune checkpoint inhibitorsICI-associated myocarditisICI-related myocarditisResonance imagingPersonalized cancer immunotherapySevere cardiovascular complicationsImmune tolerance pathwayCheckpoint inhibitorsCancer immunotherapyCardiac complicationsCombination therapyTumor cytotoxicityClinical presentationCardiovascular complicationsAdverse eventsTherapeutic efficacyOncological treatmentTherapeutic strategiesMyocarditisMulticenter Automated Central Vein Sign Detection Performs as Well as Manual Assessment for the Diagnosis of Multiple Sclerosis.
Manning A, Letchuman V, Martin M, Gombos E, Robert-Fitzgerald T, Cao Q, Raza P, O'Donnell C, Renner B, Daboul L, Rodrigues P, Ramos M, Derbyshire J, Azevedo C, Bar-Or A, Caverzasi E, Calabresi P, Cree B, Freeman L, Henry R, Longbrake E, Oh J, Papinutto N, Pelletier D, Samudralwar R, Suthiphosuwan S, Schindler M, Bilello M, Song J, Sotirchos E, Sicotte N, Al-Louzi O, Solomon A, Reich D, Ontaneda D, Sati P, Shinohara R. Multicenter Automated Central Vein Sign Detection Performs as Well as Manual Assessment for the Diagnosis of Multiple Sclerosis. American Journal Of Neuroradiology 2025, 46: 620-626. PMID: 39332906, DOI: 10.3174/ajnr.a8510.Peer-Reviewed Original ResearchCentral vein signCVS+ lesionsWhite matter lesionsMultiple sclerosisMulticenter studyProportions of white matter lesionsSuspicion of MSReceiver-operating characteristic curveFluid-attenuated inversion recoveryDiagnosis of multiple sclerosisDiagnosis of MSMagnetic resonance imagingAtypical clinical syndromeRadiological mimicsClinical syndromeDiagnostic imaging biomarkersManual assessmentT MRIClinical implementationImaging biomarkersLesionsInversion recoveryResonance imagingCharacteristic curveInter-rater reliabilityRepetitive Transcranial Magnetic Stimulation for Substance Use Disorders and Chronic Pain: a Review of the Evidence and Call for Increased Mechanistic Understanding
Michel A, Kang D, Fillingim R, Balderston N, Bond D, Steele V. Repetitive Transcranial Magnetic Stimulation for Substance Use Disorders and Chronic Pain: a Review of the Evidence and Call for Increased Mechanistic Understanding. Current Addiction Reports 2025, 12: 14. DOI: 10.1007/s40429-025-00620-3.Peer-Reviewed Original ResearchSubstance use disordersChronic painRepetitive transcranial magnetic stimulationTranscranial magnetic stimulationDiverse chronic pain conditionsChronic pain conditionsCo-occurring diseasesRTMS interventionMagnetic stimulationMagnetic resonance imagingEffective interventionsPain fieldPain conditionsSubstance use disorders fieldRepetitive transcranial magnetic stimulation applicationPainEffective treatmentUse disorderNarrative reviewClinical populationsSubstance useResonance imagingInterventionEvaluate relative efficacyClinical samplesIncidence of Surgery for Pediatric Wrist Ganglion Cysts.
Rancu A, Kammien A, Katsnelson B, Diatta F, Lewis K, Grauer J, Colen D. Incidence of Surgery for Pediatric Wrist Ganglion Cysts. Hand 2025, 15589447251314142. PMID: 39891524, PMCID: PMC11787722, DOI: 10.1177/15589447251314142.Peer-Reviewed Original ResearchWrist ganglion cystsGanglion cystYears of follow-upIncidence of surgeryPercentage of patientsNationwide analysisStatistically significant differenceMagnetic resonance imagingNonoperative managementSurgical managementPearlDiver databaseDiagnosis of ganglion cystPediatric populationFollow-upSurgical planningPatient counselingSurgeryPatientsExclusion criteriaResonance imagingFirst diagnosisCystsSignificant differenceDiagnosis codesDiagnosisInvestigative Approaches to Resilient Emotion Regulation Neurodevelopment in a South African Birth Cohort
Yates T, Sigwebela S, Seedat S, Milham M, du Plessis S, Abramson L, Niemiec E, Worthman C, Rotheram-Borus M, Salum G, Franco A, Zuanazzi A, Ahmed F, Gemmell K, Christodoulou J, Mhlaba N, Mqhele N, Ngalimane N, Sambudla A, Tottenham N, Tomlinson M. Investigative Approaches to Resilient Emotion Regulation Neurodevelopment in a South African Birth Cohort. Biological Psychiatry Global Open Science 2025, 5: 100457. PMID: 40144514, PMCID: PMC11938085, DOI: 10.1016/j.bpsgos.2025.100457.Peer-Reviewed Original ResearchSouth African birth cohortAfrican birth cohortEmotion regulationMiddle-income countriesBirth cohortNeurobiology of resilienceSelf-report measuresMagnetic resonance imagingMental health problemsNeurodevelopmental correlatesFunctional neurobiologyResonance imagingMental healthLongitudinal time pointsLow-incomeTime pointsHealth problemsDevelopmental historyAdolescent resilienceAnalytic planCohortNeurodevelopmentRegulate neurodevelopmentAdolescentsAdversitySelf-reports map the landscape of task states derived from brain imaging
Mckeown B, Goodall-Halliwell I, Wallace R, Chitiz L, Mulholland B, Karapanagiotidis T, Hardikar S, Strawson W, Turnbull A, Vanderwal T, Ho N, Wang H, Xu T, Milham M, Wang X, Zhang M, Gonzalez Alam T, Vos de Wael R, Bernhardt B, Margulies D, Wammes J, Jefferies E, Leech R, Smallwood J. Self-reports map the landscape of task states derived from brain imaging. Communications Psychology 2025, 3: 8. PMID: 39843761, PMCID: PMC11754446, DOI: 10.1038/s44271-025-00184-y.Peer-Reviewed Original ResearchFunctional magnetic resonance imagingBrain activityFunctional magnetic resonance imaging studyBrain functionPsychological statePatterns of brain activitySelf-reportTask statesDescription of brain functionIndicator of cognitionSelf-reported descriptionsBrain systemsTask performanceObject representationsIntrospective descriptionsIntrospective reportsBrain imagingMagnetic resonance imagingBrainDescription of experimentsSelf-reports of experienceTaskResonance imagingCognitionLearningModality-level obstacles and initiatives to improve representation in fetal, infant, and toddler neuroimaging research samples
Margolis E, Nelson P, Fiske A, Champaud J, Olson H, Gomez M, Dineen Á, Bulgarelli C, Troller-Renfree S, Donald K, Spann M, Howell B, Scheinost D, Korom M. Modality-level obstacles and initiatives to improve representation in fetal, infant, and toddler neuroimaging research samples. Developmental Cognitive Neuroscience 2025, 72: 101505. PMID: 39954600, PMCID: PMC11875194, DOI: 10.1016/j.dcn.2024.101505.Peer-Reviewed Original ResearchConceptsFunctional near-infrared spectroscopyEarly brain developmentNeurobiological vulnerabilityNeuroimaging researchModality-specificNeuroimaging techniquesNeurodevelopmental processesNeuroimaging modalitiesBrain developmentResearch sampleMagnetic resonance imagingNear-infrared spectroscopyEquitable representationMarginalized communitiesExcluded peopleStudy early brain developmentToddlersCranial ultrasonographyResonance imagingInsufficient resourcesTangible solutionsEarly markersGross tumor volume confidence maps prediction for soft tissue sarcomas from multi-modality medical images using a diffusion model
Dong Y, Marin T, Zhuo Y, Najem E, Moteabbed M, Xing F, Beddok A, Lahoud R, Rozenblum L, Ding Z, Liu X, Grogg K, Woo J, Chen Y, Lim R, Ma C, Fakhri G. Gross tumor volume confidence maps prediction for soft tissue sarcomas from multi-modality medical images using a diffusion model. Physics And Imaging In Radiation Oncology 2025, 33: 100734. PMID: 40123775, PMCID: PMC11926426, DOI: 10.1016/j.phro.2025.100734.Peer-Reviewed Original ResearchGross tumor volumeSoft tissue sarcomasTissue sarcomasGross tumor volume delineationManual GTV delineationsMagnetic resonance imagingComputed tomographyFluorodeoxyglucose positron emission tomographyGTV delineationT1-weighted magnetic resonance imagingSingle-modePositron emission tomographyMulti-modal medical imagesTumor volumeIntra-reader variabilityFDG-PETTreatment planningSarcomaEmission tomographyImaging modalitiesResonance imagingDiffusion modelDice indexReader variabilityPatients
2024
Gut-brain axis and neuroplasticity in health and disease: a systematic review
Di Napoli A, Pasquini L, Visconti E, Vaccaro M, Rossi-Espagnet M, Napolitano A. Gut-brain axis and neuroplasticity in health and disease: a systematic review. La Radiologia Medica 2024, 130: 327-358. PMID: 39718685, DOI: 10.1007/s11547-024-01938-0.Peer-Reviewed Original ResearchConceptsFunctional magnetic resonance imaging studyDiffusion tensor imagingHealthy subjectsArterial spin labelingGut-brain axisBrain connectivityStructural magnetic resonance imagingMagnetic resonance imaging studiesInflammatory bowel syndromeAssociated with connectivityMagnetic resonance imagingGut microbiotaBowel syndromeImaging studiesTranscranial magnetic stimulationTemporal cortexNon-human subjectsResonance imagingCurrent evidenceStructural MRISomatosensory cortexPatientsPsychiatric diseasesBrain functionTensor imagingDaily glucose variability is associated with intrahepatic fat content, β cell sensitivity, and biomarkers of glycolysis in youth with obesity
Barbieri E, Bonet J, Fox D, Nelson R, Nelson M, Nelson L, Fernandez C, Van Name M, Samuels S, Caprio S, Sabati M, Galderisi A, Sherr J, Man C, Santoro N. Daily glucose variability is associated with intrahepatic fat content, β cell sensitivity, and biomarkers of glycolysis in youth with obesity. Obesity 2024, 33: 116-124. PMID: 39658509, PMCID: PMC11666407, DOI: 10.1002/oby.24175.Peer-Reviewed Original ResearchConceptsIntrahepatic fat contentDaily glucose variabilityLiver proton density fat fractionProton density fat fractionGlucose variabilityInsulin sensitivityOral glucose tolerance testFat fractionInsulin secretionAssociated with insulin resistanceFirst-phase insulin secretionAssociated with 2-h glucoseGlucose tolerance testGlucose standard deviationMagnetic resonance imagingOral minimal modelCoefficient of variationBasal insulin secretionPediatric obesityPostprandial glucoseTolerance testCell sensitivityInsulin resistanceObesityResonance imagingPortable, low-field magnetic resonance imaging for evaluation of Alzheimer’s disease
Sorby-Adams A, Guo J, Laso P, Kirsch J, Zabinska J, Garcia Guarniz A, Schaefer P, Payabvash S, de Havenon A, Rosen M, Sheth K, Gomez-Isla T, Iglesias J, Kimberly W. Portable, low-field magnetic resonance imaging for evaluation of Alzheimer’s disease. Nature Communications 2024, 15: 10488. PMID: 39622805, PMCID: PMC11612292, DOI: 10.1038/s41467-024-54972-x.Peer-Reviewed Original ResearchConceptsWhite matter hyperintensitiesMachine learning pipelineMild cognitive impairmentAlzheimer's diseaseWhite matter hyperintensities volumeLearning pipelineAssessment of patientsIncrease accessCognitive impairmentEvaluation of Alzheimer's diseaseDementiaLF-MRIPoint-of-care assessmentMagnetic resonance imagingHippocampal volumeResonance imagingImage qualityDiseaseReduce costsAnisotropic counterpartIncreasing availabilityManual segmentationRecent advances in portable, low-field magnetic resonance imaging in cerebrovascular disease
Zabinska J, de Havenon A, Sheth K. Recent advances in portable, low-field magnetic resonance imaging in cerebrovascular disease. Current Opinion In Neurology 2024, 38: 35-39. PMID: 39624032, DOI: 10.1097/wco.0000000000001338.Peer-Reviewed Original ResearchConceptsCerebrovascular diseaseWhite matter hyperintensityHealthcare settingsHemorrhage managementAlzheimer's dementiaClinical timepointsStages of cerebrovascular diseaseHemorrhagic strokeEmergency settingWhite matter hyperintensitiesIntracerebral hemorrhage managementCardiovascular intensive careThrombolytic administrationPatient populationCerebrovascular disease progressionIntensive careMagnetic resonance imagingStrokeEndovascular reperfusionCerebrovascularCost-effectiveDisease progressionResonance imagingChronic stageCareChildhood maltreatment and the structural development of hippocampus across childhood and adolescence
Doretto V, Salto A, Schivoletto S, Zugman A, Oliveira M, Brañas M, Croci M, Ito L, Santoro M, Jackowski A, Bressan R, Rohde L, Salum G, Miguel E, Pan P. Childhood maltreatment and the structural development of hippocampus across childhood and adolescence. Psychological Medicine 2024, 54: 4528-4536. PMID: 39773537, PMCID: PMC11769901, DOI: 10.1017/s0033291724001636.Peer-Reviewed Original ResearchChildhood maltreatmentRight hippocampal volumeHippocampal volumeDepressive disorderCommunity sampleReduced right hippocampal volumeExposure to childhood maltreatmentReduction of hippocampal volumeLongitudinal studyMagnetic resonance imagingPolygenic risk scoresHippocampal structureParent reportLate childhoodSelf-reportMaltreatmentVolumetric developmentAdolescentsHippocampalChildhoodAged 6Brain magnetic resonance imagingDisordersDevelopment of hippocampusResonance imagingAssociation Between Cumulative Anticholinergic Use and White Matter Hyperintensity Burden
Li K, Krakauer C, Nelson J, Crane P, Andre J, Curl P, Yuh E, Ralston J, Gray S, MacDonald C. Association Between Cumulative Anticholinergic Use and White Matter Hyperintensity Burden. Alzheimer's & Dementia 2024, 20: e084407. PMCID: PMC11714981, DOI: 10.1002/alz.084407.Peer-Reviewed Original ResearchMagnetic resonance imagingDose-response relationshipWhite matter hyperintensitiesAssociated with higher dementia riskAssociated with greater WMH burdenAnticholinergic useCumulative anticholinergic useKaiser Permanente WashingtonMagnetic resonance imaging scansThought (ACTAnticholinergic medication useProspective cohort studyWhite matter hyperintensity burdenDementia riskAdult ChangesWhite matter hyperintensities burdensOlder adultsAnticholinergic medicationsClinical indicationsAnticholinergic burdenCohort studyLinear regression modelsTSDDsMedication useResonance imagingOVERTURE Phase 2 MRI Analysis Demonstrates Reduced Corpus Callosum Atrophy in Alzheimer's Disease
Da X, Hempel E, Hajos M, Kern R, Cimenser A. OVERTURE Phase 2 MRI Analysis Demonstrates Reduced Corpus Callosum Atrophy in Alzheimer's Disease. Alzheimer's & Dementia 2024, 20: e085446. PMCID: PMC11714734, DOI: 10.1002/alz.085446.Peer-Reviewed Original ResearchMagnetic resonance imagingMonth 3Midsagittal planeDiffusion tensor imagingPhase 3 clinical trialsRegional structural alterationsCorpus callosumT1w MRI imagesMonths of treatmentCommissural white matter tractsCorpus callosum atrophyWhite matter atrophyAlzheimer's diseaseSensory stimulationMonth 6CC atrophyClinical trialsSham groupWhite matter tractsGamma frequenciesVisual stimulationResonance imagingQuantifying articulatory variations across phonological environments: An atlas-based approach using dynamic magnetic resonance imaging
Xing F, Zhuo J, Stone M, Liu X, Reese T, Wedeen V, Prince J, Woo J. Quantifying articulatory variations across phonological environments: An atlas-based approach using dynamic magnetic resonance imaging. The Journal Of The Acoustical Society Of America 2024, 156: 4000-4009. PMID: 39670769, PMCID: PMC11646136, DOI: 10.1121/10.0034639.Peer-Reviewed Original ResearchConceptsPhonological environmentVelar consonantsArticulatory variationConsonant productionSpeech activitySpeech variationConsonant positionSpeech utterancesSpeechUtterancesMagnetic resonance imagingResonance imagingDynamic magnetic resonance imagingAdaptive behaviorConsonantsTemporal positionHuman tongueTongueMotor control studiesAtlas-based approachA Method for Multimodal IVA Fusion Within a MISA Unified Model Reveals Markers of Age, Sex, Cognition, and Schizophrenia in Large Neuroimaging Studies
Silva R, Damaraju E, Li X, Kochunov P, Ford J, Mathalon D, Turner J, van Erp T, Adali T, Calhoun V. A Method for Multimodal IVA Fusion Within a MISA Unified Model Reveals Markers of Age, Sex, Cognition, and Schizophrenia in Large Neuroimaging Studies. Human Brain Mapping 2024, 45: e70037. PMID: 39560198, PMCID: PMC11574741, DOI: 10.1002/hbm.70037.Peer-Reviewed Original ResearchConceptsMultimodal neuroimaging datasetSchizophrenia patientsNeuroimaging studiesCognitive performanceGroup differencesSchizophreniaSex effectsNeuroimaging datasetsMagnetic resonance imagingCognitionAge-associated declineControl subjectsMarkers of agingResonance imagingNon-imaging variablesSubject profilesSexNeuroimagingUK Biobank datasetRADT-45. INTEGRATION OF FUNCTIONAL MAGNETIC RESONANCE IMAGING INTO STEREOTACTIC RADIOSURGERY PLANNING TO REDUCE SYMPTOMATIC RADIATION NECROSIS
Gui C, Jenabi M, Daly J, Gillick C, Bradley T, Sze E, Maldonado R, Tiwari A, Stember J, Mankuzhy N, Yamada Y, Pike L, Pasquini L, Peck K, Ballangrud-Popovic Å, Holodny A, Imber B. RADT-45. INTEGRATION OF FUNCTIONAL MAGNETIC RESONANCE IMAGING INTO STEREOTACTIC RADIOSURGERY PLANNING TO REDUCE SYMPTOMATIC RADIATION NECROSIS. Neuro-Oncology 2024, 26: viii83-viii83. PMCID: PMC11554023, DOI: 10.1093/neuonc/noae165.0329.Peer-Reviewed Original ResearchStereotactic radiosurgerySymptomatic RNRadiation necrosisBrain metastasesNeurological symptomsDosimetric analysisTarget coverageComplications of stereotactic radiosurgeryMonths of SRSSacrificing target coverageSymptomatic radiation necrosisUnresectable brain metastasesMonths post-SRSEloquent cortical areasFunctional magnetic resonance imagingFocal neurological symptomsMagnetic resonance imagingRadiosurgery planningPost-SRSSRS plansPrimary motorEloquent areasNeurological functionPatientsResonance imagingSurvodutide for treatment of obesity: rationale and design of two randomized phase 3 clinical trials (SYNCHRONIZE™‐1 and ‐2)
Wharton S, le Roux C, Kosiborod M, Platz E, Brueckmann M, Jastreboff A, Hussain S, Pedersen S, Borowska L, Unseld A, Kloer I, Kaplan L, committees and investigators T. Survodutide for treatment of obesity: rationale and design of two randomized phase 3 clinical trials (SYNCHRONIZE™‐1 and ‐2). Obesity 2024, 33: 67-77. PMID: 39495965, PMCID: PMC11664303, DOI: 10.1002/oby.24184.Peer-Reviewed Original ResearchTreatment of obesityBaseline BMIRandomized phase 3 clinical trialOnce-weekly subcutaneous injectionsPhase 3 clinical trialsBaseline to weekDouble-blind trialObesity-related complicationsBody weight reductionAbsence of T2DSystolic blood pressureLiver fat contentType 2 diabetesMagnetic resonance imagingMeasures of glycemiaSecondary endpointsDosing flexibilityProportion of participantsLifestyle modificationInvestigated glucagonSubcutaneous injectionBlood pressureBody compositionResonance imagingObesityMRI Breast Findings
Narasimhamurthy M, O’Brien S, Andrejeva L, Nayak A. MRI Breast Findings. 2024, 235-267. DOI: 10.1007/978-3-031-65711-5_9.Peer-Reviewed Original ResearchMagnetic resonance imagingNon-mass enhancementBreast lesionsBreast magnetic resonance imagingPracticing pathologistsMagnetic resonance imaging findingsRadiologic-pathologic correlationBreast core biopsiesMalignant breast lesionsDiagnosing breast lesionsCore biopsyMRI findingsBreast biopsyImaging examinationsFalse-positive rateBiopsyResonance imagingLesionsBreastImaging techniquesPathologistsImage patterns
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply